Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01902576 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT01902576 · ClinicalTrials.gov record · last posted 2026-03-20

Chronic GVHD Response Measures Validation

StatusActive, Not Recruiting
PhaseNot specified
Started2013-06
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to develop and validate endpoint measures that can accurately determine whether patients are responding to treatment for chronic Graft-versus-Host Disease (GVHD). Hopefully, this will also lead to being better able to predict which patients will respond to what therapies.

Amendment record 23 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 23 times since 2013-07-16; most recent amendment 2026-03-18. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2019-06-03
Status change Recruiting→Active, Not Recruitingv10
Trial Details
NCT Number NCT01902576
Lead Sponsor Fred Hutchinson Cancer Center
Conditions Graft vs Host Disease
Enrollment 383 participants
Start Date 2013-06
Primary Completion 2019-09-26 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-20